- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01834833
Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient (CHIC)
October 22, 2018 updated by: Assistance Publique - Hôpitaux de Paris
Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient.
Evaluate the benefit of systematic appointment with a cardiologist a week after hospitalisation for acute heart failure.
Randomised, endpoint: number of day alive out of hospital during 6 months
Study Overview
Detailed Description
Background: the risk for rehospitalisation is very high after hospitalisation for acute heart failure.
Aim: evaluate the benefit of a consultation with a cardiologist, including echocardiography and education of the patient, between 7 and 15 days after discharge, in high risk patients, identified with BNP or incomplete therapy.
Parallel randomised study.
The main endpoint is the number of day alive out of hospital during the 6 months post discharge; statistics intention to treat comparison of the number of days alive out of hospital in the group with consultation compared with the group without consultation.
Recruitment 3 years and 4 months, follow-up 6 months.
Patients included have been hospitalised in hospital BICHAT 75018 Paris, France.
Financing is by the ministry of health (PHRQHOS)
Study Type
Interventional
Enrollment (Actual)
326
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75018
- Hôpital Bichat Claude Bernard
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Criteria of inclusion :
- Patient with decompensated heart failure hospitalized in the hospital BICHAT,
- For whom is planned a return at home,
- Valid (being able to return for a consultation to the hospital)
- Having Nt-ProBNP of exit ≥ 3500 ng /l and/or a non optimized treatment of exit - according to the doctor who has it the responsibility,
- Having signed the consent form by participation in the study.
Criteria of not inclusion :
- Age < 18 years,
- Not membership in a national insurance scheme or in the Universal Health
- Coverage (CMU)(FREE UNIVERSAL HEALTH CARE)(A patient benefiting from the Medical aid of the State (AME) cannot be included)
- Participation to another protocol of research,
- Not being reachable by telephone in 6 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
usual care without systematic cardiology evaluation between 1 and 2 weeks
|
|
Experimental: Follow-up
Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary
|
Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
days alive out of hospital 6 months post discharge
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
rehospitalisation rate at 6 months
Time Frame: 6 months
|
6 months
|
mortality at 3 and 6 months
Time Frame: 3 and 6 months
|
3 and 6 months
|
number of patients receiving beta-blocker at 6 months
Time Frame: 6 months
|
6 months
|
number of patients receiving a ACEI at 6 months
Time Frame: 6 months
|
6 months
|
QOL at 6 months
Time Frame: 6 months
|
6 months
|
autoevaluation of improvement/alteration of the patient state at 6 months
Time Frame: 6 months
|
6 months
|
number of patients receiving beta-blocker at 3 months
Time Frame: 3 months
|
3 months
|
number of patients receiving a ACEI at 3 months
Time Frame: 3 months
|
3 months
|
QOL at 3 months
Time Frame: 3 months
|
3 months
|
autoevaluation of improvement/alteration of the patient state at 3 months
Time Frame: 3 months
|
3 months
|
number of patients having an optimal treatment at 6 months
Time Frame: 6 months
|
6 months
|
number of patients having an optimal treatment at 3 months
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Guillaume JONDEAU, MD, PHD, Assistance Publique - Hôpitaux de Paris
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2013
Primary Completion (Actual)
April 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
January 17, 2013
First Submitted That Met QC Criteria
April 17, 2013
First Posted (Estimate)
April 18, 2013
Study Record Updates
Last Update Posted (Actual)
October 23, 2018
Last Update Submitted That Met QC Criteria
October 22, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P110601 - PHRQ1104
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Heart Failure
-
Idorsia Pharmaceuticals Ltd.CompletedAcute Heart Failure | Acute Decompensation of Chronic Heart Failure | New Onset of Heart FailureUnited States, United Kingdom, Israel, Switzerland, Austria, Denmark, France, Germany, Greece, Poland
-
Idorsia Pharmaceuticals Ltd.CompletedAcute Heart Failure | Acute Decompensation of Chronic Heart Failure | New Onset of Heart FailureUnited States, Hungary, Australia, Czechia, Germany, Italy, Norway, United Kingdom
-
Abiomed Inc.RecruitingHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
Shanghai Chest HospitalUnknownAcute Renal Failure | Acute Heart FailureChina
-
Magenta Medical Ltd.TerminatedCongestive Heart Failure | Heart Failure, Congestive | Acute Heart FailureCroatia, Belgium, Serbia
-
University Medical Center GroningenCompletedHeart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteNetherlands
-
Jordan Cardio Vascular Research GroupRecruitingHeart Failure | Chronic Heart Failure | Acute Heart FailureJordan
-
Azienda Ospedaliera Città della Salute e della...Caretek S.r.l. Turin, Italy; Santer Reply S.p.A. Milan, ItalyUnknownHeart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteItaly
-
Clinica Alemana de SantiagoNot yet recruitingDecompensated Heart Failure | Heart Failure Acute
-
Adrian HernandezTerminatedDecompensated Heart Failure | Acute Heart FailureUnited States
Clinical Trials on Follow-up
-
Istanbul University - Cerrahpasa (IUC)CompletedInfertility | Psychological Distress | Infertility, Female | Depression, Anxiety | Nurse's RoleTurkey
-
M.D. Anderson Cancer CenterRecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Connolly Hospital BlanchardstownCompletedGeneral Surgery | Outpatients | Virtual Clinic | Text MessagingIreland
-
Sport Injury Prevention Research CentreGeneral Electric; National Basketball AssociationCompletedTendinopathy | Sports Injuries in Children | Injury, Knee | Injury, AnkleCanada
-
Rennes University HospitalUnknown
-
Centre Hospitalier Universitaire, AmiensRecruitingQuality of Life | Pain | Lumbar Spine SurgeryFrance
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Trialbureau... and other collaboratorsRecruitingAdolescent Idiopathic ScoliosisNetherlands
-
University of IcelandMemorial Sloan Kettering Cancer Center; Landspitali University Hospital; deCODE... and other collaboratorsActive, not recruitingMonoclonal Gammopathy of Undetermined SignificanceIceland
-
Centre Hospitalier Universitaire DijonRecruitingMyocardial Infarction | Cerebrovascular AccidentsFrance
-
Rennes University HospitalMinistry of Health, FranceCompletedTelemedicine | Defibrillators, ImplantableFrance